Adagio Therapeutics, Inc. - Common Stock (NQ:ADGI)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 12, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Adagio Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

IVVD FINAL DEADLINE MONDAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IVVD, ADGI

March 30, 2023

From The Rosen Law Firm PA

Via GlobeNewswire

INVIVYD SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc. – IVVD, ADGI

February 07, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

NATIONALLY RANKED ROSEN LAW FIRM Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IVVD, ADGI

February 02, 2023

From Rosen Law Firm

Via Business Wire

Adagio Pauses FDA Emergency Use Request For Its COVID-19 Therapy ↗

April 14, 2022

Via Benzinga

Why Is Adagio Therapeutics (ADGI) Stock Up Today? ↗

March 30, 2022

Adagio recently announced that lab data has proven the effectiveness of its antibody treatment. ADGI stock is up more than 40% on the news.

Via InvestorPlace

Invivyd Presented Joint Industry Rationale on Potential Expedited Development Pathways for Monoclonal Antibodies at FDA-EMA Workshop

December 19, 2022

From Invivyd

Via GlobeNewswire

Invivyd Appoints Jeremy Gowler as Chief Operating and Commercial Officer, Promotes Pete Schmidt, M.D., to Chief Medical Officer

December 06, 2022

From Invivyd

Via GlobeNewswire

Why AMC Entertainment Is Trading Lower By 33%; Here Are 31 Stocks Moving Premarket ↗

August 22, 2022

Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares rose 48.5% to $0.56 in pre-market trading. Kiromic Biopharma said the company has determined not to pursue, at this time, the contemplated public...

Via Benzinga

Adagio's COVID-19 Antibody Meets Primary Goals Across Pre & Post-Exposure Prophylaxis, Treatment ↗

March 30, 2022

Via Benzinga

Signify Health And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

August 22, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 19, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 27, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

July 27, 2022

Good morning, investor! Wednesday starts with a breakdown of the biggest pre-market stock movers for traders to keep an eye on!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 06, 2022

Gainers

Via Benzinga

Mithril Capital’s Ajay Royan Sends Letter Thanking Adagio Therapeutics Shareholders for Support of Successful Proxy Campaign

July 05, 2022

From Mithril Capital Management LLC

Via Business Wire

30 Stocks Moving In Monday's Mid-Day Session ↗

May 23, 2022

Gainers Evolve Transition Infrastructure LP (NYSE: SNMP) shares rose 29.2% to $0.6699 after jumping around 14% on Friday.

Via Benzinga

58 Biggest Movers From Yesterday ↗

May 24, 2022

Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million.

Via Benzinga

23 Stocks Moving in Thursday's Pre-Market Session ↗

March 31, 2022

Gainers IZEA Worldwide, Inc. (NASDAQ: IZEA) rose 33.3% to $1.92 in pre-market trading after the company reported Q4 EPS results up from last year and better-than-expected sales...

Via Benzinga

51 Biggest Movers From Yesterday ↗

March 31, 2022

Gainers Forge Global Holdings, Inc. (NYSE: FRGE) jumped 73.9% to close at $37.64. Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 60.5% to close at $4.14 on Wednesday...

Via Benzinga

Mid-Afternoon Market Update: Dow Drops 100 Points; Adagio Therapeutics Shares Spike Higher ↗

March 30, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping 100 points on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 30, 2022

Gainers Adagio Therapeutics (NASDAQ:ADGI) shares rose 40.0% to $5.39 during Wednesday's regular session. Trading volume for this security as of 13:31 EST is 80.0...

Via Benzinga

S&P 500 Set to Snap 4-Day Win Streak Despite Jobs Data ↗

March 30, 2022

Stocks are still in the red this afternoon, though the major indexes have pared some of their pre-market losses on the heels of employment data.

Via Talk Markets

Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today? ↗

March 30, 2022

Penny stocks are a hot subject today with several of the top companies in the market seeing major gains on Wednesday and we know why!

Via InvestorPlace

MRNA Stock: What’s Going on With Moderna This Week? ↗

March 30, 2022

Moderna (MRNA) stock is on the move this week after the CDC and the FDA updated their Covid-19 booster shot recommendations.

Via InvestorPlace

SPCE Stock: What’s Going on With Virgin Galactic This Week? ↗

March 30, 2022

Virgin Galactic (SPCE) stock has been on the upward trend this week and we're going over all the recent news affecting the shares.

Via InvestorPlace

Mid-Day Market Update: Crude Oil Surges 3%; Revelation Biosciences Shares Plunge ↗

March 30, 2022

U.S. stocks traded lower midway through trading following the release of GDP data.

Via Benzinga

35 Stocks Moving In Wednesday's Mid-Day Session ↗

March 30, 2022

Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares jumped 82.6% to $4.71 after the company reported a year over year increase in Q4 sales results and issued Q1 sales...

Via Benzinga

Why Adagio Therapeutics Stock Is Soaring Today ↗

March 30, 2022

Adagio Therapeutics Inc (NASDAQ: ADGI) is trading higher Wednesday after the company announced its investigational drug adintrevimab (ADG20) was the first monoclonal...

Via Benzinga

Peering Into Adagio Therapeutics Inc. - Common Stock's Recent Short Interest ↗

March 30, 2022

Adagio Therapeutics Inc. - Common Stock's (NASDAQ:ADGI) short percent of float has fallen 11.69% since its last report. The company recently reported that it has 5.28 million...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 30, 2022

Gainers Adagio Therapeutics (NASDAQ:ADGI) shares increased by 52.2% to $5.86 during Wednesday's pre-market session. The company's market cap stands at $651.9 million.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.